Core Viewpoint - Hansen Pharmaceutical (002412.SZ) has indicated on its investor interaction platform that it offers products related to cold treatment, including Ganmao Qingre Granules, Baibei Yipeng Capsules, and Compound Acetaminophen and Amantadine Tablets [1] Company Summary - Hansen Pharmaceutical has a range of products aimed at treating cold symptoms [1] - The company includes wholly-owned subsidiaries in its product offerings [1]

Group 1 - The 91st National Pharmaceutical Trade Fair was held in Nanjing from November 19-21, covering over 170,000 square meters with more than 8,200 exhibition booths and over 4,000 domestic and international companies participating [1] - The event featured over 70 forums and activities, with more than 550 industry experts and scholars discussing hot topics and future trends in the pharmaceutical industry [1] - Hunan Hansen Pharmaceutical Co., Ltd., a leading company in Hunan's pharmaceutical sector, showcased its products at the Hunan exhibition area, aiming to promote high-quality development in the industry [1] Group 2 - During the Nanjing Pharmaceutical Trade Fair, Hansen Pharmaceutical's core product, Hansen Si Mo Tang Oral Liquid, was awarded a spot on the "2024-2025 Annual Family Essential Medicine Brand" list due to its excellent efficacy and market reputation [2] - Hansen Pharmaceutical adheres to the corporate value of "treating consumers well and continuously providing good products," aiming to contribute more to the health of the Chinese population [2] - The Si Mo Tang Oral Liquid is a compound traditional Chinese medicine for gastrointestinal motility, included in the national medical insurance catalog and recognized as a protected traditional Chinese medicine product [2]

Core Viewpoint - The company does not produce "Ganmaoling Granules" and clarifies its product offerings related to flu prevention and treatment [2]. Product Offerings - The company’s subsidiaries produce the following products: - Ganmao Qingre Granules - Ganmao Kousou Granules - Ganmao Zhike Granules - Sangju Ganmao Granules - Children's Ganmao Granules [2]. Flu Prevention and Treatment Products - The company’s main products for flu prevention and treatment include: - Huoxiang Zhengqi Oral Liquid - Lingyang Ganmao Granules/Tablets - Qingre Jiedu Oral Liquid - Children's Ganmao Granules - Compound Banlan Gen Granules - Refined Yinqiao Jiedu Tablets - Vitamin C Yinqiao Tablets - Compound Acetaminophen and Amantadine Capsules - Ankang Huangmin Tablets - Phenacetin and Acetaminophen Tablets - Chlorpheniramine and Acetaminophen Tablets - Compound Acetaminophen Tablets - Sustained-release Ibuprofen Tablets - Acetaminophen and Phenobarbital Injection - Compound Licorice Oral Solution - Compound Licorice Tablets - Meiyu Pseudoephedrine Oral Solution - Children's Acetaminophen and Chlorpheniramine Granules - Children's Acetaminophen, Caffeine Tablets [2].

Core Viewpoint - Taiji Group (600129.SH) currently does not produce Ganmaoling granules, but offers a variety of other cold and flu-related products [1] Product Offerings - The company produces the following products: - Ganmao Qingre granules - Ganmao Kousou granules - Ganmao Zhike granules - Sangju Ganmao granules - Children's Ganmao granules [1] Flu Prevention and Treatment - The company's main products for flu prevention and treatment include: - Huoxiang Zhengqi oral liquid - Lingyang Ganmao granules/tablets - Qingre Jiedu oral liquid - Children's Ganmao granules - Compound Banlan Gen granules - Refined Yin Qiao Jiedu tablets - Vitamin C Yin Qiao tablets - Compound Acetaminophen and Amantadine capsules - Ankang Huangmin tablets - Phenacetin and Acetaminophen tablets - Chlorpheniramine and Acetaminophen tablets - Compound Paracetamol tablets - Ibuprofen sustained-release tablets - Acetaminophen and Phenobarbital injection - Compound Glycyrrhiza oral solution - Compound Glycyrrhiza tablets - Meiyu Weima oral solution - Children's Acetaminophen and Huangnamin granules - Children's Acetaminophen, caffeine tablets [1]

Core Viewpoint - Hansen Pharmaceutical has a range of products for treating colds, including Ganmao Qingre Granules, Baibei Yilung Capsules, Compound Acetaminophen and Amantadine Tablets, and Huoxiang Zhengqi Liquid [2] Company Summary - Hansen Pharmaceutical, including its wholly-owned subsidiaries, offers various cold treatment products [2]

Core Insights - The company has successfully completed the medical material reserve task assigned by the Beijing Municipal Drug Administration, reinforcing the logistics support for regional public health emergency guarantees [1][4] - The company is a significant producer of traditional Chinese medicine under the Tongrentang Group, with a portfolio of nearly 200 products, including popular items like Ganmao Qingre Granules and Banlan Gen Granules [1][4] - The company has established a modern warehouse capable of storing 1.31 million units of traditional Chinese medicine products and has a complete intelligent logistics distribution system [1] Group 1 - The company has been recognized as a city-level medical material reserve unit, which tests its ability to fulfill social responsibilities and supply tasks [4] - A total of 460,000 boxes of five product specifications, including Ganmao Qingre Granules and Banlan Gen Granules, have been included in the reserve list [4] - The quality and safety of the reserve materials are crucial for effective emergency support, leading the company to implement a special reserve management and emergency allocation plan [4][6] Group 2 - The logistics distribution center has enhanced protective measures and established a designated area for city-level medical reserves, ensuring compliance and traceability of stored materials [4][6] - The center conducts regular emergency allocation drills every two months to improve operational accuracy and efficiency, ensuring timely delivery during emergencies [6] - The company achieved its "six zero" goals during the task period, including zero quality issues and zero delays in emergency responses [8] Group 3 - The company plans to further develop its system, personnel, and operational processes to enhance the management of medical material reserves and extend these practices to the overall drug management process [8] - The aim is to improve management precision and contribute significantly to public medication safety and regional public health security [8]

Core Viewpoint - Beijing Tongrentang Technology Development Co., Ltd. showcased traditional Chinese medicine at the 2025 China Open Tennis Tournament, blending ancient practices with modern health concepts to attract a younger audience [1][12]. Group 1: Product Showcase - The exhibition featured a variety of traditional Chinese medicine products, including Shengmai Drink, Liuwei Dihuang Wan, and Jingshi Niuhuang Jiedu Pian, highlighting the company's strong foundation in traditional medicine [3]. - A range of health products was also presented, such as health drinks, skincare masks, and hair care products, aligning with the health-oriented philosophy of the event [5]. Group 2: Engagement with Athletes - Notable tennis player Sorana Cirstea participated in a hands-on experience of making herbal sachets, demonstrating the interactive approach of the exhibition [8][10]. - The company aims to enhance global recognition of traditional Chinese medicine through athlete involvement and innovative presentations [12]. Group 3: Scent Products - The company introduced its "Bencao Zhi Yue" series and other aromatic products at the player’s banquet, which became a popular attraction among attendees [13][16]. - The scent products are developed based on the concept of "medicinal fragrance," with nearly 140 products available, focusing on benefits like sleep aid and relaxation [18]. Group 4: Market Expansion - The products were also made available in 16 authorized cultural and creative stores during the event, expanding the reach of Tongrentang's offerings to a broader audience [21].

Core Viewpoint - The China Tong Ren Tang Group hosted the third Traditional Chinese Medicine Conference, showcasing its commitment to innovation and high-quality development in traditional Chinese medicine through a comprehensive display of products and research achievements [1] Product Matrix Presentation - Tong Ren Tang Technology Company presented over twenty major products, including Xihuang Pills, Jingzhi Niuhuang Jiedu Tablets, Liuwei Dihuang Pills, and others, covering categories such as anti-cancer, tonics, kidney diseases, and detoxification [3] - The company has developed a "six-dimensional product matrix" around its more than 200 traditional Chinese medicine products, ensuring that each product meets specific consumer needs [5] Rich Product Categories - The diverse range of health products, including Ejiao honey dates, herbal essence masks, and weight loss teas, attracted significant attention from medical professionals and researchers [5] - The company emphasizes the integration of traditional techniques with modern innovation, showcasing its commitment to quality and consumer health [5] Attention to Processing Techniques - The "intangible cultural heritage" exhibition highlighted the company's traditional processing techniques, which enhance the efficacy and adaptability of traditional Chinese medicine [6][8] - The processing methods, such as the treatment of herbs to improve absorption and reduce adverse effects, were demonstrated, showcasing the company's dedication to maintaining the integrity of traditional practices [10] Research and Innovation Driving Development - The company presented solid laboratory data on major products at the conference, enhancing consumer and client understanding of product efficacy [11] - Ongoing research includes clinical studies on various traditional Chinese medicine products, providing a scientific basis for their clinical applications [11]

Group 1 - The article emphasizes the health risks associated with the misuse of antibiotics for treating viral colds, highlighting that antibiotics are ineffective against viral infections and can lead to serious side effects [1][2] - It is noted that viral colds are self-limiting, typically lasting five to seven days, and treatment should focus on symptomatic relief rather than antibiotic use [1] - The article warns that inappropriate use of antibiotics can lead to increased antibiotic resistance, making future bacterial infections harder to treat [2] Group 2 - The article outlines specific symptoms that may indicate a bacterial infection, such as worsening sore throat, cough with yellow-green phlegm, and prolonged fever, which require medical evaluation [2] - It stresses the importance of consulting healthcare professionals before using any antibiotics, as different antibiotics have varying spectra of activity and potential side effects [2]

Core Insights - Tongrentang Technology is leveraging data assets as a core strategic resource and value growth engine, enhancing operational efficiency and quality control through a deep integration of data across the entire value chain from cultivation to terminal sales [1][8] - The company has established a comprehensive traceability system for over 40 traditional Chinese medicine varieties, ensuring quality control and enhancing brand value through transparent data management [2][4] - A national sales data direct connection system has been implemented, allowing real-time aggregation of inventory and sales data from over 600 distributors and 4,000 retail terminals, enabling agile decision-making and market responsiveness [2][4] Data-Driven Decision Making - The sales data system allows for rapid response to market changes, exemplified by a 20% increase in sales of a specific product due to local weather conditions, leading to timely adjustments in inventory and distribution [4][7] - The integration of a production visualization system and SCADA technology has transformed production processes into data-driven operations, significantly improving efficiency and reducing labor costs [7][8] Quality Control and Production Efficiency - The production management dashboard provides real-time monitoring of key production metrics, enhancing the ability to identify and address bottlenecks quickly [5][7] - Post-implementation of the data-driven production system, the company reported a 40% increase in packaging line capacity and a 25% reduction in labor costs, while maintaining high product quality standards [7][8] Future Outlook - Tongrentang Technology plans to continue investing in digital operations, focusing on the integration of AI, predictive maintenance, and IoT technologies to further enhance efficiency and create sustainable long-term value [8]